Niagen Bioscience Announces First Cruise Ship Clinic Partnership with OneSpaWorld, Bringing the NAD-Boosting Benefits of Niagen IV to the High Seas

Core Insights - Niagen Bioscience has partnered with OneSpaWorld to offer Niagen IV at over 80 Medi-Spa clinics on high-end cruise ships, marking its first cruise ship clinic partnership [1][2] - This collaboration aims to expand Niagen Plus' presence and provide premium wellness experiences to vacationing consumers [2][3] Company Overview - Niagen Bioscience, Inc. is a leader in NAD+ science and healthy aging research, focusing on innovative NAD+-boosting solutions [6][9] - The company has developed a next-generation intravenous formulation of pharmaceutical-grade Niagen, designed to enhance cellular vitality and support healthy aging [3][9] Product Details - Niagen IV is a 500 mg intravenous solution that offers a better patient experience with 75% shorter infusion times and a quicker rise in NAD+ blood levels compared to traditional NAD+ IV [3][5] - The product is compounded and distributed by FDA-registered outsourcing facilities, ensuring high safety and quality standards [9][5] Market Expansion - The partnership with OneSpaWorld opens a new premium channel for Niagen IV, enhancing the company's clinical footprint, which already includes over 1,200 wellness clinics across the U.S. [2][5] - OneSpaWorld operates health and wellness services on 208 cruise ships, providing a significant opportunity for Niagen Bioscience to reach new consumers [10][5] Strategic Goals - The collaboration supports Niagen Bioscience's strategy to scale its offerings outside the U.S. and tap into the growing demand for wellness services among travelers [2][3] - The company continues to broaden its intellectual property portfolio, recently securing a patent for the methods of use of Niagen in IV and injectable formulations [3][10]